SPARK BIOPHARMA INC has a total of 15 patent applications. It decreased the IP activity by 77.0%. Its first patent ever was published in 2015. It filed its patents most often in Republic of Korea, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and measurement are CHENGDU SINO STRONG PHARMACEUTICAL CO LTD, NANHAI BEISHA PHARMACEUTICAL CO LTD and CHENGDU HONGDA PHARMACEUTICAL CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Republic of Korea | 5 | |
#2 | United States | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | China | 1 | |
#6 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Heterocyclic compounds | |
#3 | Analysing materials | |
#4 | Enzymes | |
#5 | Combinatorial chemistry | |
#6 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Park Seung Bum | 14 |
#2 | Park Han Kum | 5 |
#3 | Kim Jong Hoon | 3 |
#4 | Koo Ja Young | 2 |
#5 | Cho Wan Sang | 2 |
#6 | Youngjun Lee | 1 |
#7 | Seung Bum Park | 1 |
#8 | Bae Hwan | 1 |
#9 | Kim Jonghoon | 1 |
#10 | Lee Young Jun | 1 |
Publication | Filing date | Title |
---|---|---|
KR102011772B1 | Novel fluorophore-tetrazine compound and its use | |
WO2019231016A1 | Novel phosphor-tetrazine compound and use thereof | |
US10160766B1 | Benzopyranyl tetracycle compound and pharmaceutical composition having excellent anti-inflammatory effect comprising the same | |
KR20190044366A | Novel benzopyranyl tetracycle compound and pharmaceutical composition having excellent anti-inflammatory effect comprising the same | |
KR20180036446A | A method for target protein identification using thermal stability shift-based fluorescence difference in two-dimensional gel electrophoresis | |
KR20180036426A | Novel pyrimidine derivative, pharmaceutically acceptable salt thereof, manufacturing method thereof and pharmaceutical compositions using the same | |
KR20170078212A | INHIBITOR FOR PPARγ PHOSPHORYLATION AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME |